jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

May. 15, 2025

June. 03, 2025

jRCTs061250017

High concentrated sodium citrate versus ACD-A for leukapheresis without heparin using centrifugal separation : Open-label, randomized, controlled trial

ACD-HC trial

Fujii Keiko

Okayama University Hospital

2-5-1, Shikata-cho, Kita-ku, Okayama

+81-86-235-7768

keikofujii@s.okayama-u.ac.jp

Fujii Keiko

Okayama University Hospital

2-5-1, Shikata-chi, Kita-ku, Okayama

+81-86-235-7768

keikofujii@s.okayama-u.ac.jp

Recruiting

May. 15, 2025

May. 23, 2025
40

Interventional

randomized controlled trial

open(masking not used)

no treatment control/standard of care control

single assignment

treatment purpose

PBSC donor
Persons 16 years old and older
TBV 4.5 liter or less

Peripheral blood stem cell donors registered with the Japan Marrow Donor Program
Persons who are recommended custom priming because whose TBV and Hct values are low

16age old over
No limit

Both

PBSC donor

Peripheral blood stem cell collection using 5.3% sodium citrate solution (ACD-HC)

procedure time due to apheresis

total amount of AC
product quality assesement
collection efficiency
platelet reduction rate
incidence of adverse effect
change in electrolyte values over time
incidence rate of clumping and coagulating

Okayama University Certified Review Bord
2-5-1, Shikata-cho, Kita-ku, Okayama, Okayama

+81-86-235-6503

ouh-crrb@adm.okayama-u.ac.jp
Approval

May. 02, 2025

none

History of Changes

No Publication date
2 June. 03, 2025 (this page) Changes
1 May. 15, 2025 Detail